Cancer

Trial Library Works with Texas Oncology to Enhance Patient Clinical Trial Navigation

SAN FRANCISCO, May 20, 2025 /PRNewswire/ -- Trial Library, a technology company focused on equitable access to oncology clinical trials,…

7 months ago

From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 20, 2025 /PRNewswire/ -- Equity Insider…

7 months ago

New Study Published on the Safety and Feasibility of Pulsed Electric Field Ablation for Early-Stage Non-Small Cell Lung Cancer Prior to Surgical Resection

Innovative technology offers promising non-thermal approach to soft tissue ablation without compromising sensitive structures. REDWOOD CITY, Calif., May 20, 2025…

7 months ago

Rad AI Announces Strategic Investments from Four Leading Health Systems to Advance Enterprise AI in Healthcare

SAN FRANCISCO, May 20, 2025 /PRNewswire/ -- Rad AI today announced an additional $8 million strategic investment to its latest…

7 months ago

Mobile-health Network Solutions Signs MOU to Add AI-enabled Dental Scans and Oral Health Screening to its Telemedicine Platform

Singapore, Singapore--(Newsfile Corp. - May 20, 2025) - Mobile-health Network Solutions (Nasdaq: MNDR) ("MNDR" or "the Company"), a leading MedTech…

7 months ago

Teal Health Announces Publication of SELF-CERV Study Results in JAMA Network Open Following FDA Approval of Teal Wand™ for At-Home HPV Screening

SAN FRANCISCO, May 19, 2025 /PRNewswire/ -- Following its recent FDA approval, Teal Health® announced the publication of its multi-center pivotal…

7 months ago

Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition

Building on Volpara's breast health expertise, Lunit strengthens its U.S. presence—now delivering AI-powered breast cancer screening across 200 imaging sites…

7 months ago

Cortechs.ai and ALZ-NET Announce Strategic Collaboration to Improve Alzheimer’s Disease Care Through AI-Driven Imaging

SAN DIEGO, May 19, 2025 /PRNewswire/ -- Cortechs.ai, a global leader in AI-driven neuroimaging solutions, today announced a strategic collaboration…

7 months ago

GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals

Following the formal safety review of Cohort 1, no safety or tolerability issues were observed, allowing the company to move…

7 months ago